Free Trial
LON:KCR

KCR Residential REIT (KCR) Share Price, News & Analysis

KCR Residential REIT logo
GBX 10 -0.25 (-2.44%)
As of 06:56 AM Eastern

About KCR Residential REIT Stock (LON:KCR)

Advanced

Key Stats

Today's Range
10
11.60
50-Day Range
10
13.20
52-Week Range
7.20
14
Volume
5,500 shs
Average Volume
16,794 shs
Market Capitalization
£4.17 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive KCR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for KCR Residential REIT and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

KCR Stock News Headlines

Is *BSEM* Oversold??
BioStem Technologies Inc. (OTC: BSEM) is emerging as one of the most exciting MedTech stories of 2025. The company delivered record-breaking revenues in 2024 and Q1 2025, including $72.5 million in net revenue for Q1 — a 73% increase over the prior year — and six consecutive quarters of positive adjusted EBITDA. With cash reserves rising to $30.8 million and a growing patent portfolio of 58 issued and 68 pending patents, BSEM is scaling profitably while advancing its proprietary BioREtain® technology, which has shown clinically superior results for chronic, non-healing wounds. National recognition is adding to the momentum, with CEO Jason Matuszewski named EY Entrepreneur of the Year 2025 Florida Award winner, validating the leadership driving this high-growth MedTech powerhouse.tc pixel
See More Headlines

KCR Stock Analysis - Frequently Asked Questions

KCR Residential REIT's stock was trading at GBX 8.50 at the beginning of 2025. Since then, KCR stock has increased by 17.6% and is now trading at GBX 10.

KCR Residential REIT (LON:KCR) released its quarterly earnings data on Monday, March, 31st. The company reported $1.04 earnings per share for the quarter. KCR Residential REIT had a negative trailing twelve-month return on equity of 9.29% and a negative net margin of 66.04%.

Shares of KCR stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that KCR Residential REIT investors own include Capital & Counties Properties PLC (CAPC) and AgriFORCE Growing Systems (AGRI).

Company Calendar

Last Earnings
3/31/2025
Today
10/16/2025

Industry, Sector and Symbol

Stock Exchange
LON
Industry
REIT - Residential
Sub-Industry
N/A
Current Symbol
LON:KCR
CIK
N/A
Fax
N/A
Employees
7
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
GBX (0.01)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-£1.19 million
Net Margins
-66.04%
Pretax Margin
N/A
Return on Equity
-9.29%
Return on Assets
0.03%

Debt

Debt-to-Equity Ratio
112.83
Current Ratio
7.84
Quick Ratio
6.14

Sales & Book Value

Annual Sales
£1.35 million
Price / Sales
3.10
Cash Flow
GBX 6.32 per share
Price / Cash Flow
1.58
Book Value
GBX 29.60 per share
Price / Book
0.34

Miscellaneous

Outstanding Shares
41,670,000
Free Float
N/A
Market Cap
£4.17 million
Optionable
Not Optionable
Beta
0.18
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (LON:KCR) was last updated on 10/16/2025 by MarketBeat.com Staff
From Our Partners